On November 19, 2021, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines. Now, all individuals 18 years of age and older are eligible for a single booster dose after completing the initial vaccination series with the Pfizer, Moderna, or Johnson & Johnson/Janssen vaccines.
The Centers for Disease Control (CDC) now recommends COVID-19 booster vaccines for all three vaccines available in the United States.
- Individuals who have received either the Pfizer-BioNTech or Moderna vaccine are eligible for a booster 6 months after completing the primary 2-dose vaccination series.
- Individuals who have received the Johnson & Johnson/Janssen vaccine are eligible for a booster 2 months after receiving the primary single-shot vaccine.
The CDC has approved a “mix-and-match” policy meaning any of the three COVID-19 vaccines available in the U.S. can be taken as a booster shot, regardless of which vaccine a person had for their primary vaccination.